IL76405A - 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them - Google Patents

1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them

Info

Publication number
IL76405A
IL76405A IL76405A IL7640585A IL76405A IL 76405 A IL76405 A IL 76405A IL 76405 A IL76405 A IL 76405A IL 7640585 A IL7640585 A IL 7640585A IL 76405 A IL76405 A IL 76405A
Authority
IL
Israel
Prior art keywords
diacyl
pharmaceutical compositions
compositions containing
oxindole derivatives
oxindole
Prior art date
Application number
IL76405A
Other languages
English (en)
Other versions
IL76405A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IL87454A priority Critical patent/IL87454A/xx
Publication of IL76405A0 publication Critical patent/IL76405A0/xx
Priority to IL87454A priority patent/IL87454A0/xx
Publication of IL76405A publication Critical patent/IL76405A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL76405A 1984-09-19 1985-09-18 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them IL76405A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL87454A IL87454A (en) 1984-09-19 1985-09-18 1-acyl-2-oxindole derivatives
IL87454A IL87454A0 (en) 1984-09-19 1988-08-15 1-acyl-2-oxindole derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65237284A 1984-09-19 1984-09-19
US06/747,194 US4690943A (en) 1984-09-19 1985-06-20 Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds

Publications (2)

Publication Number Publication Date
IL76405A0 IL76405A0 (en) 1986-01-31
IL76405A true IL76405A (en) 1990-03-19

Family

ID=27096283

Family Applications (1)

Application Number Title Priority Date Filing Date
IL76405A IL76405A (en) 1984-09-19 1985-09-18 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them

Country Status (10)

Country Link
US (1) US4690943A (ja)
EP (1) EP0175551B1 (ja)
AU (1) AU556948B2 (ja)
CA (1) CA1256104A (ja)
DE (1) DE3570078D1 (ja)
DK (1) DK162443C (ja)
GR (1) GR852244B (ja)
IE (1) IE58140B1 (ja)
IL (1) IL76405A (ja)
PH (1) PH21580A (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3568776D1 (en) * 1984-02-07 1989-04-20 Pfizer 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4652658A (en) * 1984-03-19 1987-03-24 Pfizer Inc. Process for making 2-oxindole-1-carboxamides and intermediates therefor
US4808601A (en) * 1984-09-19 1989-02-28 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
EP0208510B1 (en) * 1985-07-09 1991-09-11 Pfizer Inc. 1-substituted oxindole-3-carboxamines as antiinflammatory and analgesic agents
DK288287A (da) * 1986-06-09 1987-12-10 Pfizer Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
GB8720693D0 (en) * 1987-09-03 1987-10-07 Glaxo Group Ltd Chemical compounds
HU215112B (hu) * 1989-01-10 1998-12-28 Pfizer Inc. Eljárás gyulladáscsökkentő 1-heteroaril-3-acil-2-oxindol-származékok előállítására
US5300655A (en) * 1989-04-18 1994-04-05 Pfizer Inc. 2-carboxy-thiophene derivatives
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5359068A (en) * 1993-06-28 1994-10-25 Pfizer Inc. Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one
US6469181B1 (en) * 1995-01-30 2002-10-22 Catalytica, Inc. Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles
JP2004529110A (ja) 2001-03-06 2004-09-24 アストラゼネカ アクチボラグ 脈管損傷活性を有するインドール誘導体
MY144968A (en) 2005-04-11 2011-11-30 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
MY145694A (en) 2005-04-11 2012-03-30 Xenon Pharmaceuticals Inc Spiroheterocyclic compounds and their uses as therapeutic agents
AR056317A1 (es) * 2005-04-20 2007-10-03 Xenon Pharmaceuticals Inc Compuestos de oxindol y composicion farmaceutica
EP2073806B1 (en) 2006-10-12 2012-02-15 Xenon Pharmaceuticals Inc. Use of spiro-oxindole compounds as therapeutic agents
CN106928247A (zh) 2008-10-17 2017-07-07 泽农医药公司 螺羟吲哚化合物及其作为治疗剂的用途
EP2350091B1 (en) 2008-10-17 2015-06-03 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
EP2246326A1 (de) 2009-05-02 2010-11-03 Bayer CropScience AG Verfahren zur Herstellung von Oxindolen und ortho-substituierten Anilinen und ihre Verwendung als Zwischenprodukte für Synthesen
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
PE20170202A1 (es) 2009-10-14 2017-03-24 Xenon Pharmaceuticals Inc Metodos sinteticos para compuestos espiro-oxoindol
MA34083B1 (fr) 2010-02-26 2013-03-05 Xenon Pharmaceuticals Inc Compositions pharmaceutques de composé spiro-oxindole pour administration topique et leur utilisation en tant qu'agents thérapeutiques
WO2012028162A1 (de) 2010-09-01 2012-03-08 Bayer Cropscience Ag Verfahren zur herstellung von oxindolen und ortho-substituierten anilinen und ihre verwendung als zwischenprodukte für synthesen
US9682033B2 (en) 2015-02-05 2017-06-20 Teva Pharmaceuticals International Gmbh Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
CN104744338A (zh) * 2015-03-31 2015-07-01 天津维智精细化工有限公司 一种6-氯羟吲哚的合成方法
WO2016179157A1 (en) 2015-05-05 2016-11-10 Carafe Drug Innovation, Llc Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3189617A (en) * 1961-02-03 1965-06-15 Sterling Drug Inc 1-aryloxindoles and their preparation
GB1089071A (en) * 1964-02-28 1967-11-01 Merck & Co Inc Indole derivatives
AT259553B (de) * 1966-03-04 1968-01-25 Italiana Sint Spa Verfahren zur Herstellung von Indolderivaten
US3462450A (en) * 1966-06-29 1969-08-19 Merck & Co Inc Chemical compounds
GB1158532A (en) * 1967-01-05 1969-07-16 Centre Nat Rech Scient 2-Oxoindoline-3-Carboxylic Acids and Esters thereof
US3631177A (en) * 1967-04-18 1971-12-28 Smith Kline French Lab 3-phenacyl-2-oxoindolines
US3519592A (en) * 1967-04-18 1970-07-07 Smithkline Corp Indole compounds
BE714717A (ja) * 1967-05-12 1968-09-30
FR7337M (ja) * 1968-01-11 1969-10-13
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
GB1436771A (en) * 1973-02-16 1976-05-26 Labaz Indole derivatives and process for preparing the same
US3975531A (en) * 1973-10-02 1976-08-17 A. H. Robins Company, Incorporated 4-(5- And 7-)benzoylindolin-2-ones and pharmaceutical uses thereof
US4221716A (en) * 1979-02-16 1980-09-09 A. H. Robins Company, Inc. Intermediate and process for the preparation of 7-acylindolin-2-ones
DE3300522A1 (de) * 1982-01-21 1983-07-28 Sandoz-Patent-GmbH, 7850 Lörrach 3,3-dialkyl- und 3,3-alkylen-indolinderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate sie enthaltend

Also Published As

Publication number Publication date
IE852297L (en) 1986-03-19
AU4756185A (en) 1986-04-10
IL76405A0 (en) 1986-01-31
DE3570078D1 (en) 1989-06-15
GR852244B (ja) 1986-01-17
DK162443C (da) 1992-03-23
DK162443B (da) 1991-10-28
IE58140B1 (en) 1993-07-14
EP0175551A1 (en) 1986-03-26
EP0175551B1 (en) 1989-05-10
CA1256104A (en) 1989-06-20
DK422485A (da) 1986-03-20
US4690943A (en) 1987-09-01
PH21580A (en) 1987-12-11
DK422485D0 (da) 1985-09-18
AU556948B2 (en) 1986-11-27

Similar Documents

Publication Publication Date Title
NZ210940A (en) 1,2,3-trihydro-3-(1h-imidazol-1-ylmethyl)-4h-carbazol-4-one derivatives and pharmaceutical compositions
IL76405A (en) 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them
NZ212895A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
IL77004A0 (en) 5-amino-4-hydroxyvaleryl derivatives,their manufacture and pharmaceutical compositions containing them
NZ211031A (en) 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions
IL74865A0 (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
IL76188A (en) 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them
IL75943A0 (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
NZ214175A (en) Cholecalciferol derivatives and pharmaceutical compositions
IL72562A (en) 6,7-dimethoxy-4-piperidino-quinazoline derivatives and pharmaceutical compositions containing them
NZ210818A (en) 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
IL76823A0 (en) 1,2,4-triazolo-carbamates,their preparation and pharmaceutical compositions containing them
NZ225466A (en) 1-aminoalkyl-1h-indole derivatives and pharmaceutical compositions containing certain derivatives thereof
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
IL74270A0 (en) 1,2,4-triazole derivatives,their preparation and pharmaceutical compositions containing them
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
IL76312A (en) Xenocoumacins and derivatives thereof,their preparation and pharmaceutical compositions containing them
EP0159652A3 (en) 4-phenylphthalazine derivatives, their preparation and pharmaceutical compositions containing them
DE3561808D1 (en) Phenylnonatetraenic-acid derivatives, their preparation and pharmaceutical compositions containing them
IL73278A0 (en) Pharmaceutical compositions containing 1,2-dithiolan derivatives,certain such derivatives and their preparation
IL77426A (en) 2,6-dimethyl-8alpha-pivaloyl-amino-9,10-didehydro-ergoline,its production and pharmaceutical compositions containing it
NZ210817A (en) N-hydroxy-alkoxynaphthalinalkanamine derivatives and pharmaceutical compositions
IL80733A0 (en) 2,2'-bi-1h-imidazoles and pharmaceutical compositions containing same
NZ213629A (en) 4,4-diphenylpiperidine derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired